ANDA 61392, held by Bristol Myers Squibb. Ampicillin/Ampicillin Trihydrate.
As of Nov 16, 2026, ANDA 61392 (Principen), held by Bristol Myers Squibb, was first approved by FDA on Mar 3, 1971, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 3, 1971 | Original application | Approved | None posted |
| PrincipenEQ 250MG BASE · capsule;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| PrincipenEQ 500MG BASE · capsule;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Feb 20, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Jul 11, 1997 | Supplement 2Labeling | Approved | None posted |
| Feb 29, 1996 | Supplement 1Manufacturing | Approved | None posted |
| Mar 3, 1971 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters